ASO Therapy: Hope for Genetic Neurological Diseases episode artwork

EPISODE · Jan 30, 2018 · 12 MIN

ASO Therapy: Hope for Genetic Neurological Diseases

from JAMA Medical News

In this Medical News podcast, JAMA Associate Editor Christopher Muth, MD, discusses the use of antisense oligonucleotide therapies for treatment of neurological diseases with Stefan Pulst, MD, Chairman of Neurology at the University of Utah.

NOW PLAYING

ASO Therapy: Hope for Genetic Neurological Diseases

0:00 12:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of JAMA Medical News?

This episode is 12 minutes long.

When was this JAMA Medical News episode published?

This episode was published on January 30, 2018.

What is this episode about?

In this Medical News podcast, JAMA Associate Editor Christopher Muth, MD, discusses the use of antisense oligonucleotide therapies for treatment of neurological diseases with Stefan Pulst, MD, Chairman of Neurology at the University of Utah.

Can I download this JAMA Medical News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!